Trial intelligence / Profile preview

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control

NCT06358755Active, not recruiting

Sponsor
The Hong Kong Polytechnic University
Start
Jul 2024
Primary completion
Apr 2026
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Randomised trial of NVK002 in myopia (2 arms), sponsored by The Hong Kong Polytechnic University. Primary endpoints: Changes in cycloplegic refraction at 18 months and Changes in axial length at 18 months. Started Jul 2024; status: active, not recruiting.

02

Drugs

NVK002
03

Conditions

myopia

Beyond the preview

Go deeper on NCT06358755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06358755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call